SAT0356 Discriminant Capacity of Clinical Efficacy Measures, Alone or in Combination with NSAID Intake, in Detecting Anti-TNF Treatment Effect in Spondyloarthritis

Abstract

BackgroundIn placebo (PBO)-controlled trials of anti-TNF therapy in spondyloarthritis (SpA), background NSAIDs are maintained at stable levels to facilitate demonstration of the anti-TNF treatment effect. In daily practice, most patients...